https://vitalspanwire.com/news/circle-pharma-cid-165-cyclin-cancer-drug-financingVitalspan Wireen2026-09-21T21:02:30.598ZCircle Pharma raises $92.5 million to advance oral cyclin-targeting cancer drughttps://vitalspanwire.com/news/early-gut-microbiome-patterns-type-1-diabetes-riskVitalspan Wireen2026-09-21T16:02:02.259ZEarly gut-microbiome patterns linked to type 1 diabetes risk in childrenhttps://vitalspanwire.com/news/tusc2-brain-protein-maintenance-sex-differences-miceVitalspan Wireen2026-09-21T11:01:53.743ZTusc2 loss disrupts brain protein maintenance differently in male and female micehttps://vitalspanwire.com/news/glepaglutide-short-bowel-syndrome-chmp-positive-opinionVitalspan Wireen2026-09-20T21:02:04.338ZEU panel backs glepaglutide for adults with short bowel syndromehttps://vitalspanwire.com/news/fda-imlunestrant-abemaciclib-esr1-breast-cancer-approvalVitalspan Wireen2026-09-20T16:02:07.016ZFDA approves imlunestrant–abemaciclib combination for ESR1-mutated breast cancerhttps://vitalspanwire.com/news/longevitybench-ai-aging-biology-model-performanceVitalspan Wireen2026-09-20T11:02:02.269ZLongevityBench tests AI models on aging biology, finding uneven performance